Alphonse Galdes
CIK 1789471 · EVP Pharmaceutical Oper & Tech · last filed 2022-01-21
Alphonse Galdes is an EVP Pharmaceutical Oper & Tech who has filed 6 SEC Form 4 insider transactions across 1 company since 2020. The most recent filing, for BIIB, was dated Jan 21, 2022. Current disclosed insider exposure totals $1.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.21M
1
6
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BIIB | EVP Pharmaceutical Oper & Tech | 6,033 | $200.05 | $1.21M | $0 | 6 | 2022-01-21 |
Recent Filings
6 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-01-21 | BIIB | Grant (A) | +658 | $0 | EDGAR |
| 2021-02-22 | BIIB | Grant (A) | — | $0 | EDGAR |
| 2021-02-17 | BIIB | Mixed | +858 | -$198.8K | EDGAR |
| 2021-01-29 | BIIB | Grant (A) | +818 | $0 | EDGAR |
| 2020-02-19 | BIIB | Mixed | +311 | -$43.3K | EDGAR |
| 2020-02-14 | BIIB | Mixed | +803 | -$116.4K | EDGAR |